All In Biotech

Drugs by condition

Drugs approved for urinary tract infection

Brand-name prescription drugs and biologics whose FDA label lists urinary tract infection as an approved use. Matched on the label phrases: "urinary tract infection".

Last checked: Nov 20, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations

Brand-name drugs approved

3

Still marketed, NDA or BLA

Drug classes

1

Novel drugs

2

New molecular entities and new biologics

In development

7

Investigational drugs in Phase 2 or 3

Newest approvals

The most recently first-approved brand-name drugs for urinary tract infection.

  • Utebzi (Tebipenem Pivoxil Hydrobromide) · Glaxosmithkline NovelPriority reviewJun 17, 2026
  • Cipro (Ciprofloxacin) · Bayer Hlthcare Accelerated approvalSep 26, 1997
  • Cipro (Ciprofloxacin Hydrochloride) · Bayer Hlthcare NovelAccelerated approvalPriority reviewOct 22, 1987

All approved drugs for urinary tract infection, by class

Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 29 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.

Class not listed in FDA's data (3)

  • Utebzi Tebipenem Pivoxil Hydrobromide · Glaxosmithkline · 2026
  • Cipro Ciprofloxacin Hydrochloride · Bayer Hlthcare · 1987
  • Cipro Ciprofloxacin · Bayer Hlthcare · 1997

Drugs in development for urinary tract infection

Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.

Search the pipeline
  • PralurbactamPhase 33 trials

    Qilu Pharmaceutical Co., Ltd. · Hospital-acquired Bacterial Pneumonia (HABP), Ventilator-associated Bacterial Pneumonia (VABP), Complicated Intra-abdominal Infection (cIAI)

  • Meiji Seika Pharma Co., Ltd. · Complicated Urinary Tract Infection, Acute Pyelonephritis, Hospital-acquired Bacterial Pneumonia

  • Meiji Seika Pharma Co., Ltd. · Complicated Urinary Tract Infection, Acute Pyelonephritis, Hospital-acquired Bacterial Pneumonia

  • HRS-8427Phase 32 trials

    Jiangsu HengRui Medicine Co., Ltd. · Complicated Urinary Tract Infection(cUTI), Including Acute Pyelonephritis(AP), Hospital-acquired Bacterial Pneumonia (HABP), Ventilator-associated Bacterial Pneumonia (VABP)

  • nacubactamPhase 32 trials

    Meiji Seika Pharma Co., Ltd. · Complicated Urinary Tract Infection, Acute Pyelonephritis, Hospital-acquired Bacterial Pneumonia

  • TMPSMX, Trimethoprim-sulfamethoxazolePhase 32 trials

    Locus Biosciences · Urinary Tract Infections, Candidemia, Mycoses

  • antibioticsPhase 23 trials

    TenNor Therapeutics (Zhongshan) Limited · Prosthetic Joint Infection (PJI), Periprosthetic Joint Infection (PJI), Acute Pyelonephritis

More on urinary tract infection: recruiting trials · published research

Related in infectious disease and vaccines: HIV · Hepatitis B · Hepatitis C · COVID-19 · Influenza · RSV · Pneumonia · Skin infections · C. difficile infection · Fungal infections

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.